Click for best price
Intranasal Drug Delivery System Market Size, Share 2022
This report contains market size and forecasts of Intranasal Drug Delivery System in global, including the following market information:
Global Intranasal Drug Delivery System Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Intranasal Drug Delivery System Market Sales, 2017-2022, 2023-2028, (K Units)
Global top five Intranasal Drug Delivery System companies in 2021 (%)
The global Intranasal Drug Delivery System market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period 2022-2028.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Nasal Drops Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Intranasal Drug Delivery System include Aptar Pharma, Nemera, Teleflex, Mystic Pharmaceuticals, Zeteo Medical, Johnson & Johnson, GlaxoSmithKline Plc, Aegis Therapeutics LLC and H&T Presspart Manufacturing Ltd., etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Intranasal Drug Delivery System manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Intranasal Drug Delivery System Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Intranasal Drug Delivery System Market Segment Percentages, by Type, 2021 (%)
Nasal Drops
Nasal Sprays
Nasal Gels
Nasal Suspensions and Emulsion
Nasal Powders
Global Intranasal Drug Delivery System Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Intranasal Drug Delivery System Market Segment Percentages, by Application, 2021 (%)
Hospital
Clinic
Home Care
Others
Global Intranasal Drug Delivery System Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Intranasal Drug Delivery System Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Intranasal Drug Delivery System revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Intranasal Drug Delivery System revenues share in global market, 2021 (%)
Key companies Intranasal Drug Delivery System sales in global market, 2017-2022 (Estimated), (K Units)
Key companies Intranasal Drug Delivery System sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Aptar Pharma
Nemera
Teleflex
Mystic Pharmaceuticals
Zeteo Medical
Johnson & Johnson
GlaxoSmithKline Plc
Aegis Therapeutics LLC
H&T Presspart Manufacturing Ltd.
AstraZeneca Plc
Becton
BD
Novartis AG
Vectura Group Plc
| Report Attributes |
Report Details |
| Report Title |
Intranasal Drug Delivery System Market, Global Outlook and Forecast 2022-2028 |
| Historical Year |
2018 to 2022 (Data from 2010 can be provided as per availability) |
| Base Year |
2021 |
| Forecast Year |
2029 |
| Number of Pages |
71 Pages |
| Customization Available |
Yes, the report can be customized as per your need. |
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Intranasal Drug Delivery System Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Intranasal Drug Delivery System Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Intranasal Drug Delivery System Overall Market Size
2.1 Global Intranasal Drug Delivery System Market Size: 2021 VS 2028
2.2 Global Intranasal Drug Delivery System Revenue, Prospects & Forecasts: 2017-2028
2.3 Global Intranasal Drug Delivery System Sales: 2017-2028
3 Company Landscape
3.1 Top Intranasal Drug Delivery System Players in Global Market
3.2 Top Global Intranasal Drug Delivery System Companies Ranked by Revenue
3.3 Global Intranasal Drug Delivery System Revenue by Companies
3.4 Global Intranasal Drug Delivery System Sales by Companies
3.5 Global Intranasal Drug Delivery System Price by Manufacturer (2017-2022)
3.6 Top 3 and Top 5 Intranasal Drug Delivery System Companies in Global Market, by Revenue in 2021
3.7 Global Manufacturers Intranasal Drug Delivery System Product Type
3.8 Tier 1, Tier 2 and Tier 3 Intranasal Drug Delivery System Players in Global Market
3.8.1 List of Global Tier 1 Intranasal Drug Delivery System Companies
3.8.2 List of Global Tier 2 and Tier 3 Intranasal Drug Delivery System Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type - Global Intranasal Drug Delivery System Market Size Markets, 2021 & 2028
4.1.2 Nasal Drops
4.1.3 Nasal Sprays
4.1.4 Nasal Gels
4.1.5 Nasal Suspensions and Emulsion
4.1.6 Nasal Powders
4.2 By Type - Global Intranasal Drug Delivery System Revenue & Forecasts
4.2.1 By Type - Global Intranasal Drug Delivery System Revenue, 2017-2022
4.2.2 By Type - Global Intranasal Drug Delivery System Revenue, 2023-2028
4.2.3 By Type - Global Intranasal Drug Delivery System Revenue Market Share, 2017-2028
4.3 By Type - Global Intranasal Drug Delivery System Sales & Forecasts
4.3.1 By Type - Global Intranasal Drug Delivery System Sales, 2017-2022
4.3.2 By Type - Global Intranasal Drug Delivery System Sales, 2023-2028
4.3.3 By Type - Global Intranasal Drug Delivery System Sales Market Share, 2017-2028
4.4 By Type - Global Intranasal Drug Delivery System Price (Manufacturers Selling Prices), 2017-2028
5 Sights By Application
5.1 Overview
5.1.1 By Application - Global Intranasal Drug Delivery System Market Size, 2021 & 2028
5.1.2 Hospital
5.1.3 Clinic
5.1.4 Home Care
5.1.5 Others
5.2 By Application - Global Intranasal Drug Delivery System Revenue & Forecasts
5.2.1 By Application - Global Intranasal Drug Delivery System Revenue, 2017-2022
5.2.2 By Application - Global Intranasal Drug Delivery System Revenue, 2023-2028
5.2.3 By Application - Global Intranasal Drug Delivery System Revenue Market Share, 2017-2028
5.3 By Application - Global Intranasal Drug Delivery System Sales & Forecasts
5.3.1 By Application - Global Intranasal Drug Delivery System Sales, 2017-2022
5.3.2 By Application - Global Intranasal Drug Delivery System Sales, 2023-2028
5.3.3 By Application - Global Intranasal Drug Delivery System Sales Market Share, 2017-2028
5.4 By Application - Global Intranasal Drug Delivery System Price (Manufacturers Selling Prices), 2017-2028
6 Sights by Region
6.1 By Region - Global Intranasal Drug Delivery System Market Size, 2021 & 2028
6.2 By Region - Global Intranasal Drug Delivery System Revenue & Forecasts
6.2.1 By Region - Global Intranasal Drug Delivery System Revenue, 2017-2022
6.2.2 By Region - Global Intranasal Drug Delivery System Revenue, 2023-2028
6.2.3 By Region - Global Intranasal Drug Delivery System Revenue Market Share, 2017-2028
6.3 By Region - Global Intranasal Drug Delivery System Sales & Forecasts
6.3.1 By Region - Global Intranasal Drug Delivery System Sales, 2017-2022
6.3.2 By Region - Global Intranasal Drug Delivery System Sales, 2023-2028
6.3.3 By Region - Global Intranasal Drug Delivery System Sales Market Share, 2017-2028
6.4 North America
6.4.1 By Country - North America Intranasal Drug Delivery System Revenue, 2017-2028
6.4.2 By Country - North America Intranasal Drug Delivery System Sales, 2017-2028
6.4.3 US Intranasal Drug Delivery System Market Size, 2017-2028
6.4.4 Canada Intranasal Drug Delivery System Market Size, 2017-2028
6.4.5 Mexico Intranasal Drug Delivery System Market Size, 2017-2028
6.5 Europe
6.5.1 By Country - Europe Intranasal Drug Delivery System Revenue, 2017-2028
6.5.2 By Country - Europe Intranasal Drug Delivery System Sales, 2017-2028
6.5.3 Germany Intranasal Drug Delivery System Market Size, 2017-2028
6.5.4 France Intranasal Drug Delivery System Market Size, 2017-2028
6.5.5 U.K. Intranasal Drug Delivery System Market Size, 2017-2028
6.5.6 Italy Intranasal Drug Delivery System Market Size, 2017-2028
6.5.7 Russia Intranasal Drug Delivery System Market Size, 2017-2028
6.5.8 Nordic Countries Intranasal Drug Delivery System Market Size, 2017-2028
6.5.9 Benelux Intranasal Drug Delivery System Market Size, 2017-2028
6.6 Asia
6.6.1 By Region - Asia Intranasal Drug Delivery System Revenue, 2017-2028
6.6.2 By Region - Asia Intranasal Drug Delivery System Sales, 2017-2028
6.6.3 China Intranasal Drug Delivery System Market Size, 2017-2028
6.6.4 Japan Intranasal Drug Delivery System Market Size, 2017-2028
6.6.5 South Korea Intranasal Drug Delivery System Market Size, 2017-2028
6.6.6 Southeast Asia Intranasal Drug Delivery System Market Size, 2017-2028
6.6.7 India Intranasal Drug Delivery System Market Size, 2017-2028
6.7 South America
6.7.1 By Country - South America Intranasal Drug Delivery System Revenue, 2017-2028
6.7.2 By Country - South America Intranasal Drug Delivery System Sales, 2017-2028
6.7.3 Brazil Intranasal Drug Delivery System Market Size, 2017-2028
6.7.4 Argentina Intranasal Drug Delivery System Market Size, 2017-2028
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Intranasal Drug Delivery System Revenue, 2017-2028
6.8.2 By Country - Middle East & Africa Intranasal Drug Delivery System Sales, 2017-2028
6.8.3 Turkey Intranasal Drug Delivery System Market Size, 2017-2028
6.8.4 Israel Intranasal Drug Delivery System Market Size, 2017-2028
6.8.5 Saudi Arabia Intranasal Drug Delivery System Market Size, 2017-2028
6.8.6 UAE Intranasal Drug Delivery System Market Size, 2017-2028
7 Manufacturers & Brands Profiles
7.1 Aptar Pharma
7.1.1 Aptar Pharma Corporate Summary
7.1.2 Aptar Pharma Business Overview
7.1.3 Aptar Pharma Intranasal Drug Delivery System Major Product Offerings
7.1.4 Aptar Pharma Intranasal Drug Delivery System Sales and Revenue in Global (2017-2022)
7.1.5 Aptar Pharma Key News
7.2 Nemera
7.2.1 Nemera Corporate Summary
7.2.2 Nemera Business Overview
7.2.3 Nemera Intranasal Drug Delivery System Major Product Offerings
7.2.4 Nemera Intranasal Drug Delivery System Sales and Revenue in Global (2017-2022)
7.2.5 Nemera Key News
7.3 Teleflex
7.3.1 Teleflex Corporate Summary
7.3.2 Teleflex Business Overview
7.3.3 Teleflex Intranasal Drug Delivery System Major Product Offerings
7.3.4 Teleflex Intranasal Drug Delivery System Sales and Revenue in Global (2017-2022)
7.3.5 Teleflex Key News
7.4 Mystic Pharmaceuticals
7.4.1 Mystic Pharmaceuticals Corporate Summary
7.4.2 Mystic Pharmaceuticals Business Overview
7.4.3 Mystic Pharmaceuticals Intranasal Drug Delivery System Major Product Offerings
7.4.4 Mystic Pharmaceuticals Intranasal Drug Delivery System Sales and Revenue in Global (2017-2022)
7.4.5 Mystic Pharmaceuticals Key News
7.5 Zeteo Medical
7.5.1 Zeteo Medical Corporate Summary
7.5.2 Zeteo Medical Business Overview
7.5.3 Zeteo Medical Intranasal Drug Delivery System Major Product Offerings
7.5.4 Zeteo Medical Intranasal Drug Delivery System Sales and Revenue in Global (2017-2022)
7.5.5 Zeteo Medical Key News
7.6 Johnson & Johnson
7.6.1 Johnson & Johnson Corporate Summary
7.6.2 Johnson & Johnson Business Overview
7.6.3 Johnson & Johnson Intranasal Drug Delivery System Major Product Offerings
7.6.4 Johnson & Johnson Intranasal Drug Delivery System Sales and Revenue in Global (2017-2022)
7.6.5 Johnson & Johnson Key News
7.7 GlaxoSmithKline Plc
7.7.1 GlaxoSmithKline Plc Corporate Summary
7.7.2 GlaxoSmithKline Plc Business Overview
7.7.3 GlaxoSmithKline Plc Intranasal Drug Delivery System Major Product Offerings
7.7.4 GlaxoSmithKline Plc Intranasal Drug Delivery System Sales and Revenue in Global (2017-2022)
7.7.5 GlaxoSmithKline Plc Key News
7.8 Aegis Therapeutics LLC
7.8.1 Aegis Therapeutics LLC Corporate Summary
7.8.2 Aegis Therapeutics LLC Business Overview
7.8.3 Aegis Therapeutics LLC Intranasal Drug Delivery System Major Product Offerings
7.8.4 Aegis Therapeutics LLC Intranasal Drug Delivery System Sales and Revenue in Global (2017-2022)
7.8.5 Aegis Therapeutics LLC Key News
7.9 H&T Presspart Manufacturing Ltd.
7.9.1 H&T Presspart Manufacturing Ltd. Corporate Summary
7.9.2 H&T Presspart Manufacturing Ltd. Business Overview
7.9.3 H&T Presspart Manufacturing Ltd. Intranasal Drug Delivery System Major Product Offerings
7.9.4 H&T Presspart Manufacturing Ltd. Intranasal Drug Delivery System Sales and Revenue in Global (2017-2022)
7.9.5 H&T Presspart Manufacturing Ltd. Key News
7.10 AstraZeneca Plc
7.10.1 AstraZeneca Plc Corporate Summary
7.10.2 AstraZeneca Plc Business Overview
7.10.3 AstraZeneca Plc Intranasal Drug Delivery System Major Product Offerings
7.10.4 AstraZeneca Plc Intranasal Drug Delivery System Sales and Revenue in Global (2017-2022)
7.10.5 AstraZeneca Plc Key News
7.11 Becton
7.11.1 Becton Corporate Summary
7.11.2 Becton Intranasal Drug Delivery System Business Overview
7.11.3 Becton Intranasal Drug Delivery System Major Product Offerings
7.11.4 Becton Intranasal Drug Delivery System Sales and Revenue in Global (2017-2022)
7.11.5 Becton Key News
7.12 BD
7.12.1 BD Corporate Summary
7.12.2 BD Intranasal Drug Delivery System Business Overview
7.12.3 BD Intranasal Drug Delivery System Major Product Offerings
7.12.4 BD Intranasal Drug Delivery System Sales and Revenue in Global (2017-2022)
7.12.5 BD Key News
7.13 Novartis AG
7.13.1 Novartis AG Corporate Summary
7.13.2 Novartis AG Intranasal Drug Delivery System Business Overview
7.13.3 Novartis AG Intranasal Drug Delivery System Major Product Offerings
7.13.4 Novartis AG Intranasal Drug Delivery System Sales and Revenue in Global (2017-2022)
7.13.5 Novartis AG Key News
7.14 Vectura Group Plc
7.14.1 Vectura Group Plc Corporate Summary
7.14.2 Vectura Group Plc Business Overview
7.14.3 Vectura Group Plc Intranasal Drug Delivery System Major Product Offerings
7.14.4 Vectura Group Plc Intranasal Drug Delivery System Sales and Revenue in Global (2017-2022)
7.14.5 Vectura Group Plc Key News
8 Global Intranasal Drug Delivery System Production Capacity, Analysis
8.1 Global Intranasal Drug Delivery System Production Capacity, 2017-2028
8.2 Intranasal Drug Delivery System Production Capacity of Key Manufacturers in Global Market
8.3 Global Intranasal Drug Delivery System Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Intranasal Drug Delivery System Supply Chain Analysis
10.1 Intranasal Drug Delivery System Industry Value Chain
10.2 Intranasal Drug Delivery System Upstream Market
10.3 Intranasal Drug Delivery System Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Intranasal Drug Delivery System Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Key Players of Intranasal Drug Delivery System in Global Market
Table 2. Top Intranasal Drug Delivery System Players in Global Market, Ranking by Revenue (2021)
Table 3. Global Intranasal Drug Delivery System Revenue by Companies, (US$, Mn), 2017-2022
Table 4. Global Intranasal Drug Delivery System Revenue Share by Companies, 2017-2022
Table 5. Global Intranasal Drug Delivery System Sales by Companies, (K Units), 2017-2022
Table 6. Global Intranasal Drug Delivery System Sales Share by Companies, 2017-2022
Table 7. Key Manufacturers Intranasal Drug Delivery System Price (2017-2022) & (US$/Unit)
Table 8. Global Manufacturers Intranasal Drug Delivery System Product Type
Table 9. List of Global Tier 1 Intranasal Drug Delivery System Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Intranasal Drug Delivery System Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type ? Global Intranasal Drug Delivery System Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Global Intranasal Drug Delivery System Revenue (US$, Mn), 2017-2022
Table 13. By Type - Global Intranasal Drug Delivery System Revenue (US$, Mn), 2023-2028
Table 14. By Type - Global Intranasal Drug Delivery System Sales (K Units), 2017-2022
Table 15. By Type - Global Intranasal Drug Delivery System Sales (K Units), 2023-2028
Table 16. By Application ? Global Intranasal Drug Delivery System Revenue, (US$, Mn), 2021 & 2028
Table 17. By Application - Global Intranasal Drug Delivery System Revenue (US$, Mn), 2017-2022
Table 18. By Application - Global Intranasal Drug Delivery System Revenue (US$, Mn), 2023-2028
Table 19. By Application - Global Intranasal Drug Delivery System Sales (K Units), 2017-2022
Table 20. By Application - Global Intranasal Drug Delivery System Sales (K Units), 2023-2028
Table 21. By Region ? Global Intranasal Drug Delivery System Revenue, (US$, Mn), 2021 VS 2028
Table 22. By Region - Global Intranasal Drug Delivery System Revenue (US$, Mn), 2017-2022
Table 23. By Region - Global Intranasal Drug Delivery System Revenue (US$, Mn), 2023-2028
Table 24. By Region - Global Intranasal Drug Delivery System Sales (K Units), 2017-2022
Table 25. By Region - Global Intranasal Drug Delivery System Sales (K Units), 2023-2028
Table 26. By Country - North America Intranasal Drug Delivery System Revenue, (US$, Mn), 2017-2022
Table 27. By Country - North America Intranasal Drug Delivery System Revenue, (US$, Mn), 2023-2028
Table 28. By Country - North America Intranasal Drug Delivery System Sales, (K Units), 2017-2022
Table 29. By Country - North America Intranasal Drug Delivery System Sales, (K Units), 2023-2028
Table 30. By Country - Europe Intranasal Drug Delivery System Revenue, (US$, Mn), 2017-2022
Table 31. By Country - Europe Intranasal Drug Delivery System Revenue, (US$, Mn), 2023-2028
Table 32. By Country - Europe Intranasal Drug Delivery System Sales, (K Units), 2017-2022
Table 33. By Country - Europe Intranasal Drug Delivery System Sales, (K Units), 2023-2028
Table 34. By Region - Asia Intranasal Drug Delivery System Revenue, (US$, Mn), 2017-2022
Table 35. By Region - Asia Intranasal Drug Delivery System Revenue, (US$, Mn), 2023-2028
Table 36. By Region - Asia Intranasal Drug Delivery System Sales, (K Units), 2017-2022
Table 37. By Region - Asia Intranasal Drug Delivery System Sales, (K Units), 2023-2028
Table 38. By Country - South America Intranasal Drug Delivery System Revenue, (US$, Mn), 2017-2022
Table 39. By Country - South America Intranasal Drug Delivery System Revenue, (US$, Mn), 2023-2028
Table 40. By Country - South America Intranasal Drug Delivery System Sales, (K Units), 2017-2022
Table 41. By Country - South America Intranasal Drug Delivery System Sales, (K Units), 2023-2028
Table 42. By Country - Middle East & Africa Intranasal Drug Delivery System Revenue, (US$, Mn), 2017-2022
Table 43. By Country - Middle East & Africa Intranasal Drug Delivery System Revenue, (US$, Mn), 2023-2028
Table 44. By Country - Middle East & Africa Intranasal Drug Delivery System Sales, (K Units), 2017-2022
Table 45. By Country - Middle East & Africa Intranasal Drug Delivery System Sales, (K Units), 2023-2028
Table 46. Aptar Pharma Corporate Summary
Table 47. Aptar Pharma Intranasal Drug Delivery System Product Offerings
Table 48. Aptar Pharma Intranasal Drug Delivery System Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 49. Nemera Corporate Summary
Table 50. Nemera Intranasal Drug Delivery System Product Offerings
Table 51. Nemera Intranasal Drug Delivery System Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 52. Teleflex Corporate Summary
Table 53. Teleflex Intranasal Drug Delivery System Product Offerings
Table 54. Teleflex Intranasal Drug Delivery System Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 55. Mystic Pharmaceuticals Corporate Summary
Table 56. Mystic Pharmaceuticals Intranasal Drug Delivery System Product Offerings
Table 57. Mystic Pharmaceuticals Intranasal Drug Delivery System Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 58. Zeteo Medical Corporate Summary
Table 59. Zeteo Medical Intranasal Drug Delivery System Product Offerings
Table 60. Zeteo Medical Intranasal Drug Delivery System Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 61. Johnson & Johnson Corporate Summary
Table 62. Johnson & Johnson Intranasal Drug Delivery System Product Offerings
Table 63. Johnson & Johnson Intranasal Drug Delivery System Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 64. GlaxoSmithKline Plc Corporate Summary
Table 65. GlaxoSmithKline Plc Intranasal Drug Delivery System Product Offerings
Table 66. GlaxoSmithKline Plc Intranasal Drug Delivery System Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 67. Aegis Therapeutics LLC Corporate Summary
Table 68. Aegis Therapeutics LLC Intranasal Drug Delivery System Product Offerings
Table 69. Aegis Therapeutics LLC Intranasal Drug Delivery System Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 70. H&T Presspart Manufacturing Ltd. Corporate Summary
Table 71. H&T Presspart Manufacturing Ltd. Intranasal Drug Delivery System Product Offerings
Table 72. H&T Presspart Manufacturing Ltd. Intranasal Drug Delivery System Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 73. AstraZeneca Plc Corporate Summary
Table 74. AstraZeneca Plc Intranasal Drug Delivery System Product Offerings
Table 75. AstraZeneca Plc Intranasal Drug Delivery System Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 76. Becton Corporate Summary
Table 77. Becton Intranasal Drug Delivery System Product Offerings
Table 78. Becton Intranasal Drug Delivery System Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 79. BD Corporate Summary
Table 80. BD Intranasal Drug Delivery System Product Offerings
Table 81. BD Intranasal Drug Delivery System Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 82. Novartis AG Corporate Summary
Table 83. Novartis AG Intranasal Drug Delivery System Product Offerings
Table 84. Novartis AG Intranasal Drug Delivery System Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 85. Vectura Group Plc Corporate Summary
Table 86. Vectura Group Plc Intranasal Drug Delivery System Product Offerings
Table 87. Vectura Group Plc Intranasal Drug Delivery System Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 88. Intranasal Drug Delivery System Production Capacity (K Units) of Key Manufacturers in Global Market, 2020-2022 (K Units)
Table 89. Global Intranasal Drug Delivery System Capacity Market Share of Key Manufacturers, 2020-2022
Table 90. Global Intranasal Drug Delivery System Production by Region, 2017-2022 (K Units)
Table 91. Global Intranasal Drug Delivery System Production by Region, 2023-2028 (K Units)
Table 92. Intranasal Drug Delivery System Market Opportunities & Trends in Global Market
Table 93. Intranasal Drug Delivery System Market Drivers in Global Market
Table 94. Intranasal Drug Delivery System Market Restraints in Global Market
Table 95. Intranasal Drug Delivery System Raw Materials
Table 96. Intranasal Drug Delivery System Raw Materials Suppliers in Global Market
Table 97. Typical Intranasal Drug Delivery System Downstream
Table 98. Intranasal Drug Delivery System Downstream Clients in Global Market
Table 99. Intranasal Drug Delivery System Distributors and Sales Agents in Global Market
List of Figures
Figure 1. Intranasal Drug Delivery System Segment by Type
Figure 2. Intranasal Drug Delivery System Segment by Application
Figure 3. Global Intranasal Drug Delivery System Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Intranasal Drug Delivery System Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Intranasal Drug Delivery System Revenue, 2017-2028 (US$, Mn)
Figure 7. Intranasal Drug Delivery System Sales in Global Market: 2017-2028 (K Units)
Figure 8. The Top 3 and 5 Players Market Share by Intranasal Drug Delivery System Revenue in 2021
Figure 9. By Type - Global Intranasal Drug Delivery System Sales Market Share, 2017-2028
Figure 10. By Type - Global Intranasal Drug Delivery System Revenue Market Share, 2017-2028
Figure 11. By Type - Global Intranasal Drug Delivery System Price (US$/Unit), 2017-2028
Figure 12. By Application - Global Intranasal Drug Delivery System Sales Market Share, 2017-2028
Figure 13. By Application - Global Intranasal Drug Delivery System Revenue Market Share, 2017-2028
Figure 14. By Application - Global Intranasal Drug Delivery System Price (US$/Unit), 2017-2028
Figure 15. By Region - Global Intranasal Drug Delivery System Sales Market Share, 2017-2028
Figure 16. By Region - Global Intranasal Drug Delivery System Revenue Market Share, 2017-2028
Figure 17. By Country - North America Intranasal Drug Delivery System Revenue Market Share, 2017-2028
Figure 18. By Country - North America Intranasal Drug Delivery System Sales Market Share, 2017-2028
Figure 19. US Intranasal Drug Delivery System Revenue, (US$, Mn), 2017-2028
Figure 20. Canada Intranasal Drug Delivery System Revenue, (US$, Mn), 2017-2028
Figure 21. Mexico Intranasal Drug Delivery System Revenue, (US$, Mn), 2017-2028
Figure 22. By Country - Europe Intranasal Drug Delivery System Revenue Market Share, 2017-2028
Figure 23. By Country - Europe Intranasal Drug Delivery System Sales Market Share, 2017-2028
Figure 24. Germany Intranasal Drug Delivery System Revenue, (US$, Mn), 2017-2028
Figure 25. France Intranasal Drug Delivery System Revenue, (US$, Mn), 2017-2028
Figure 26. U.K. Intranasal Drug Delivery System Revenue, (US$, Mn), 2017-2028
Figure 27. Italy Intranasal Drug Delivery System Revenue, (US$, Mn), 2017-2028
Figure 28. Russia Intranasal Drug Delivery System Revenue, (US$, Mn), 2017-2028
Figure 29. Nordic Countries Intranasal Drug Delivery System Revenue, (US$, Mn), 2017-2028
Figure 30. Benelux Intranasal Drug Delivery System Revenue, (US$, Mn), 2017-2028
Figure 31. By Region - Asia Intranasal Drug Delivery System Revenue Market Share, 2017-2028
Figure 32. By Region - Asia Intranasal Drug Delivery System Sales Market Share, 2017-2028
Figure 33. China Intranasal Drug Delivery System Revenue, (US$, Mn), 2017-2028
Figure 34. Japan Intranasal Drug Delivery System Revenue, (US$, Mn), 2017-2028
Figure 35. South Korea Intranasal Drug Delivery System Revenue, (US$, Mn), 2017-2028
Figure 36. Southeast Asia Intranasal Drug Delivery System Revenue, (US$, Mn), 2017-2028
Figure 37. India Intranasal Drug Delivery System Revenue, (US$, Mn), 2017-2028
Figure 38. By Country - South America Intranasal Drug Delivery System Revenue Market Share, 2017-2028
Figure 39. By Country - South America Intranasal Drug Delivery System Sales Market Share, 2017-2028
Figure 40. Brazil Intranasal Drug Delivery System Revenue, (US$, Mn), 2017-2028
Figure 41. Argentina Intranasal Drug Delivery System Revenue, (US$, Mn), 2017-2028
Figure 42. By Country - Middle East & Africa Intranasal Drug Delivery System Revenue Market Share, 2017-2028
Figure 43. By Country - Middle East & Africa Intranasal Drug Delivery System Sales Market Share, 2017-2028
Figure 44. Turkey Intranasal Drug Delivery System Revenue, (US$, Mn), 2017-2028
Figure 45. Israel Intranasal Drug Delivery System Revenue, (US$, Mn), 2017-2028
Figure 46. Saudi Arabia Intranasal Drug Delivery System Revenue, (US$, Mn), 2017-2028
Figure 47. UAE Intranasal Drug Delivery System Revenue, (US$, Mn), 2017-2028
Figure 48. Global Intranasal Drug Delivery System Production Capacity (K Units), 2017-2028
Figure 49. The Percentage of Production Intranasal Drug Delivery System by Region, 2021 VS 2028
Figure 50. Intranasal Drug Delivery System Industry Value Chain
Figure 51. Marketing Channels
